Rion (6823) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Mar, 2026Executive summary
Net sales for Q1 FY2025 were ¥6,355 million, up 5.7% year-over-year.
Operating profit declined 25.9% year-over-year to ¥691 million.
Ordinary profit fell 27.0% year-over-year to ¥714 million.
Profit attributable to owners of parent dropped 41.4% year-over-year to ¥400 million.
Comprehensive income decreased 35.2% year-over-year to ¥437 million.
Financial highlights
Profit per share (basic) for Q1 FY2025 was ¥32.56, down from ¥55.58 in Q1 FY2024.
Total assets as of June 2024 were ¥37,586 million, up from ¥37,140 million as of March 2024.
Shareholders' equity stood at ¥29,254 million with an equity ratio of 77.8%.
Outlook and guidance
Full-year FY2025 net sales forecast at ¥26,900 million, up 4.6% year-over-year.
Full-year operating profit projected at ¥3,700 million, up 0.3% year-over-year.
Profit attributable to owners of parent forecast at ¥2,700 million, up 1.8% year-over-year.
Profit per share for the full year expected to be ¥219.32.
Latest events from Rion
- Record H1 sales and profits, with semiconductor demand driving particle-measurement growth.6823
Q2 2024 - Record FY2024 results were led by particle measurement, with growth forecast through FY2027.6823
Q4 2024 - First-quarter sales and profits rose year-over-year, with strong margins and positive full-year outlook.6823
Q1 2027 - Record FY26 results underpin growth plans, while investment pressures selected segment profits.6823
Q4 2026 - Record H1 results led by particle instruments support FY3/25 growth guidance.6823
Q2 2025 - Solid nine-month growth and higher dividend forecast, with continued profit gains expected.6823
Q3 2025 - Record FY2025 growth, led by particle measurement, sets up continued but steadier expansion.6823
Q4 2025 - Record first-half results support FY26 guidance of ¥28.9bn sales and ¥4.4bn operating profit.6823
Q2 2026 - Strong profit growth and higher margins reported for Q1 FY2025, with positive full-year outlook.6823
Q1 2026